Hatchtech Pty Ltd Competitors

About Genomic Health Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that help optimize cancer care by addressing the overtreatment of the disease, one of the greatest issues in healthcare today. With its Oncotype IQ® Genomic Intelligence Platform, the company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of clinical and genomic big data into actionable results for treatment planning throughout the cancer patient journey, from diagnosis to treatment selection and monitoring. The Oncotype IQ portfolio of genomic tests and services currently consists of the company's flagship line of Oncotype DX gene expression tests that have been used to guide treatment decisions for more than 750,000 cancer patients worldwide. Genomic Health is expanding its test portfolio to include additional liquid- and tissue-based tests, including the recently launched Oncotype SEQ® Liquid Select™ test. The company is based in Redwood City, California, with international headquarters in Geneva, Switzerland. For more information, please visit, www.GenomicHealth.com and follow the company on Twitter: @GenomicHealth, Facebook, YouTube and LinkedIn. About Oncotype DX® The Oncotype DX® portfolio of breast, colon and prostate cancer tests applies advanced genomic science to reveal the unique biology of a tumor in order to optimize cancer treatment decisions. The company's flagship product, the Oncotype DX Breast Recurrence Score®, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer. Additionally, the Oncotype DX Breast DCIS Score™ predicts the likelihood of recurrence in a pre-invasive form of breast cancer called DCIS. In prostate cancer, the Oncotype DX Genomic Prostate Score™ predicts disease aggressiveness and further clarifies the current and future risk of the cancer prior to treatment intervention. With more than 750,000 patients tested in more than 90 countries, the Oncotype DX tests have redefined personalized medicine by making genomics a critical part of cancer diagnosis and treatment. To learn more about Oncotype DX tests, visit www.OncotypeIQ.com, www.MyBreastCancerTreatment.org or www.MyProstateCancerTreatment.org.

Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Barnett Educational Services, Cambridge Meeting Planners and Healthtech Publishing, which includes publications such as Bio-IT World, Clinical Informatics News, and Diagnostics World, as well as numerous e-newsletters. Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with a heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. The executive team has a combined 170+ years of experience and drives the CHI portfolio to deliver cutting-edge information and the most up-to-date research.

Vanguard Pharma offers you a completely outsourced, cost-effective, turn-key sales force solution that helps you achieve your corporate objectives with less financial and legal risk and more flexibility than “going it alone.” It is Vanguard's mission to set a new higher standard in pharmaceutical contract sales. We aim to delight our customers by achieving their sales objectives via exceptional execution of customized sales solutions. Look to Vanguard to help you when the need arises for any of the following: - National Programs | Completely outsourced, turn-key contract sales force programs, including live sales force staffing, tele-sales, and virtual sales - HR Management | Honor headcount caps without worry - Vanguard can recruit, hire and employ individuals to work on your behalf as Vanguard contracted employees - Sales Recruitment |Tap into our extensive roster of qualified and pre-screened sales applicants for a fraction of the cost of a traditional recruiter. All of our representatives are salaried employees and have an extensive compensation/incentivization and benefits package. We operate in Canada (corporate office – London, Ontario) and the United States (corporate office – Mahwah, NJ). We invite you to learn more by contacting us directly. We think you’ll be glad you did!!!